Bioinformatics-Driven New Immune Target Discovery in Disease.

Area of Science:

• Immunology and Bioinformatics
• Computational Biology and Autoimmune Disease Research

Background:

• Biomolecular network analysis is established for cancer gene discovery but underexplored for autoimmune disease antigen identification.
• Autoimmune diseases lack comprehensive molecular targets for diagnosis and therapy.

Purpose of the Study:

• To explore the utility of biomolecular network analysis in discovering novel autoantigens for autoimmune diseases.
• To identify potential biomarkers for systemic lupus erythematosus and Behcet's disease using bioinformatics tools.

Main Methods:

• Constructed antigen networks using NetworkAnalyst, GeneMANIA, and ToppGene.
• Identified candidate antigens by analyzing network-derived gene lists.
• Validated bioinformatics findings using enzyme-linked immunosorbent assay, mass spectrometry, and immunoprecipitation in 130 patients.

Main Results:

• Identified histone H2AX as a potential antigen for systemic lupus erythematosus.
• Screened heat shock protein HSP 90-alpha (HSP90AA1) as a novel biomarker candidate for Behcet's disease.
• Clinical validation confirmed the bioinformatics predictions using patient samples.

Conclusions:

• Integrating multiple molecular network approaches is effective for discovering new immune targets in autoimmune diseases.
• Histone H2AX and HSP90AA1 represent promising targets for further investigation in systemic lupus erythematosus and Behcet's disease, respectively.
• This computational strategy offers a powerful platform for advancing autoimmune disease research and biomarker discovery.